Article
Immunization by exposure to live virus (SIV <sub>mne</sub> /HIV-2 <sub>287</sub> ) during antiretroviral drug prophylaxis reduces risk of subsequent viral challenge
2020-10-01
Abstract excerpt
<h4>Rationale/Study Design</h4> A major challenge in the development of HIV vaccines is finding immunogens that elicit protection against a broad range of viral strains. Immunity to a narrow range of viral strains may protect infants of HIV-infected women or partners discordant for HIV. We hypothesized that immunization to the relevant viral variants could be achieved by exposure to infectious virus during prophy...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 49f9e4bc-b5e0-509d-9101-d45c64c7fc78
- DOI
- 10.1101/2020.09.30.320820
